Stock Analysis Report

Header cover image

HABA LaboratoriesInc

Market Cap


Last Updated

2021/07/30 16:49 UTC

Data Sources

Company Financials

Executive Summary

HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. More Details

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

Share Price & News

How has HABA LaboratoriesInc's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: 4925 is less volatile than 75% of JP stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: 4925's weekly volatility (2%) has been stable over the past year.

Market Performance

7 Day Return




JP Personal Products


JP Market

1 Year Return




JP Personal Products


JP Market

Return vs Industry: 4925 underperformed the JP Personal Products industry which returned 12.1% over the past year.

Return vs Market: 4925 underperformed the JP Market which returned 27.3% over the past year.

Shareholder returns

7 Day-2.1%-1.7%1.0%
30 Day-4.4%-3.9%-1.1%
90 Day-14.8%-2.0%1.3%
1 Year-1.8%-2.7%13.5%12.1%30.0%27.3%
3 Year-62.8%-63.7%-13.7%-16.9%19.0%10.8%
5 Year20.6%16.5%83.3%71.4%67.6%49.1%

Long-Term Price Volatility Vs. Market

How volatile is HABA LaboratoriesInc's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is HABA LaboratoriesInc undervalued compared to its fair value and its price relative to the market?


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: 4925 (¥3820) is trading above our estimate of fair value (¥687.93)

Significantly Below Fair Value: 4925 is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: 4925 is poor value based on its PE Ratio (66.9x) compared to the JP Personal Products industry average (35.7x).

PE vs Market: 4925 is poor value based on its PE Ratio (66.9x) compared to the JP market (16.2x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4925's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 4925 is good value based on its PB Ratio (1.2x) compared to the JP Personal Products industry average (3.5x).

Future Growth

How is HABA LaboratoriesInc forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Household industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HABA LaboratoriesInc has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has HABA LaboratoriesInc performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4925 has high quality earnings.

Growing Profit Margin: 4925's current net profit margins (1.5%) are lower than last year (7.1%).

Past Earnings Growth Analysis

Earnings Trend: 4925's earnings have declined by 8.1% per year over the past 5 years.

Accelerating Growth: 4925's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4925 had negative earnings growth (-83.5%) over the past year, making it difficult to compare to the Personal Products industry average (-18.7%).

Return on Equity

High ROE: 4925's Return on Equity (1.8%) is considered low.

Financial Health

How is HABA LaboratoriesInc's financial position?

Financial Position Analysis

Short Term Liabilities: 4925's short term assets (¥11.3B) exceed its short term liabilities (¥3.5B).

Long Term Liabilities: 4925's short term assets (¥11.3B) exceed its long term liabilities (¥2.0B).

Debt to Equity History and Analysis

Debt Level: 4925's debt to equity ratio (32.5%) is considered satisfactory.

Reducing Debt: 4925's debt to equity ratio has reduced from 44.8% to 32.5% over the past 5 years.

Debt Coverage: 4925's debt is not well covered by operating cash flow (13.6%).

Interest Coverage: 4925's interest payments on its debt are well covered by EBIT (32.4x coverage).

Balance Sheet


What is HABA LaboratoriesInc current dividend yield, its reliability and sustainability?


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 4925's dividend (1.05%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.33%).

High Dividend: 4925's dividend (1.05%) is low compared to the top 25% of dividend payers in the JP market (3%).

Stability and Growth of Payments

Stable Dividend: 4925's dividends per share have been stable in the past 10 years.

Growing Dividend: 4925's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (70%), 4925's dividend payments are covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Eiji Suehiro

no data


Mr. Eiji Suehiro serves as the President and Representative Director of HABA Laboratories Inc.

Leadership Team

Experienced Management: 4925's management team is seasoned and experienced (10.1 years average tenure).

Board Members

Experienced Board: 4925's board of directors are seasoned and experienced ( 10.1 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

HABA Laboratories,Inc.'s company bio, employee growth, exchange listings and data sources

Key Information

  • Name: HABA Laboratories,Inc.
  • Ticker: 4925
  • Exchange: JASDAQ
  • Founded: 1983
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: JP¥14.446b
  • Shares outstanding: 3.78m
  • Website: https://www.haba.com

Number of Employees


  • HABA Laboratories,Inc.
  • 1-24-11, Kanda Sudacho
  • Chiyoda-ku
  • Tokyo
  • 101-0041
  • Japan



HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, a...

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/30 16:49
End of Day Share Price2021/07/30 00:00
Annual Earnings2021/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.